Fulcrum Therapeutics, Inc. (FULC) Dividend History

Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing therapies that address genetically defined diseases. The company leverages its gene control platform to identify and develop treatments aimed at restoring or modulating gene expression to improve patient outcomes.

26 Landsdowne Street, Cambridge, MA, 02139
Phone: 617-651-8851
Website: https://www.fulcrumtx.com

Dividend History

Fulcrum Therapeutics, Inc. currently does not pay dividends

Company News

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fulcrum Therapeutics, a clinical-stage biopharmaceutical company, announced that it granted stock options to a new employee as an inducement to join the company.

GlobeNewswire Inc.
BHVN Stock Up as Rare Neurological Disease Study Meets Primary Goal

Biohaven's pipeline candidate, troriluzole, met the primary endpoint in a pivotal study for the treatment of spinocerebellar ataxia, a rare neurological disease. The study showed a 50-70% delay in disease progression compared to untreated patients.

Benzinga

Featured Companies: ANIP BHVN KRYS
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers

Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers are included in this Analyst Blog.

Zacks Investment Research

Featured Companies: BMY MRNA NVAX
5 Huge Analyst Calls: Netflix Grabs Another Buy Call; Dick's Slashed at BofA

Investing.com

Featured Companies: DKS GRAB MPW NFLX

Page data last updated 07/22/2025 16:26:46 UTC